An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

NCT00465088 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

199

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia
Mixed Dyslipidemia

Interventions

DRUG: Niacin ER/Simvastatin Tablets
DRUG: atorvastatin

Sponsor

Abbott